← Back to Search

Behavioral Intervention

Walking Intervention Group for Cognitive Impairment (WalkCog-MCI Trial)

N/A
Waitlist Available
Led By Jeffrey Keller, PhD
Research Sponsored by Pennington Biomedical Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

WalkCog-MCI Trial Summary

The purpose of this study is to determine the effects of a coordinated intervention of cognitive remediation training (CRT) and walking intervention on cognition and gait in the elderly.

Eligible Conditions
  • Cognitive Impairment

WalkCog-MCI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effects of interventions on cognition
Secondary outcome measures
Effects of interventions on gait

WalkCog-MCI Trial Design

4Treatment groups
Experimental Treatment
Group I: Walking Intervention GroupExperimental Treatment1 Intervention
60 minutes of walking and 30 minutes of reading stimulation three times a week
Group II: Healthy Living GroupExperimental Treatment1 Intervention
60 minute Healthy Living Class and 30 minutes of reading stimulation three times a week.
Group III: Combination GroupExperimental Treatment1 Intervention
30 minutes of Cognitive Remediation therapy and 60 minutes of walking three times a week
Group IV: Cognitive Remediation Therapy GroupExperimental Treatment1 Intervention
30 minute Cognitive Remediation Therapy and 60 minute Healthy Living Class three time per week
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Combination Group
2008
N/A
~360

Find a Location

Who is running the clinical trial?

Pennington Biomedical Research CenterLead Sponsor
305 Previous Clinical Trials
182,036 Total Patients Enrolled
Jeffrey Keller, PhDPrincipal InvestigatorPennington Biomedical Research Center
1 Previous Clinical Trials
513 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment
Jeffrey Keller 2013. "Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01801943.
~29 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top